CSPIA
IMGN

Cary Street Partners Investment Advisory’s Immunogen Inc IMGN Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,500
Closed -$23.8K – 1865
2023
Q3 		$23.8K Hold
1,500
– – ﹤0.01% 1063
2023
Q2 		$28.3K Buy
+1,500
New +$17.7K ﹤0.01% 962

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cary Street Partners Investment Advisory's IMGN Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 1,500 shares — an estimated $23.8K sold.

Cary Street Partners Investment Advisory first reported a position in IMGN in Q2 2023 and held it in 2 quarters. The position peaked at $28.3K in Q2 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 1,500 Immunogen Inc shares in Q4 2023, an estimated $23.8K.
  • Cary Street Partners Investment Advisory first reported a position in Immunogen Inc in Q2 2023 and held it in 2 quarters.
  • Cary Street Partners Investment Advisory's Immunogen Inc position peaked at $28.3K in Q2 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.